loading

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Apr 24, 2025
pulisher
Apr 17, 2025

BofA Adjusts Price Target on Agios Pharmaceuticals to $52 From $54, Keeps Buy Rating - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Agios Pharmaceuticals (AGIO) Price Target Lowered by BofA but Buy Rating Maintained | AGIO Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025 | AGIO Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Agios Pharmaceuticals to Host Conference Call for Q1 2025 Financial Results on May 1, 2025 - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

Rare Disease Biotech Agios Sets Q1 2025 Earnings Call: Key Updates Expected May 1 - Stock Titan

Apr 17, 2025
pulisher
Apr 14, 2025

Anemia Market Set to Witness Significant Growth by 2032, Driven by Rising Awareness and Novel Oral Alternatives | DelveInsight - Barchart.com

Apr 14, 2025
pulisher
Apr 12, 2025

Trexquant Investment LP Increases Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Agios Pharmaceuticals director Jacqualyn Fouse sells $194,172 in stock By Investing.com - Investing.com India

Apr 11, 2025
pulisher
Apr 10, 2025

Agios Pharmaceuticals director Jacqualyn Fouse sells $194,172 in stock - Investing.com Australia

Apr 10, 2025
pulisher
Apr 10, 2025

Agios Pharmaceuticals Director Sells Shares to Cover Tax Obligations - TradingView

Apr 10, 2025
pulisher
Apr 08, 2025

Agios stock touches 52-week low at $24.33 amid market challenges - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

Agios stock touches 52-week low at $24.33 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

RBC Capital Sticks to Its Buy Rating for Agios Pharma (AGIO) - The Globe and Mail

Apr 04, 2025
pulisher
Apr 03, 2025

Small to Mid-Cap Biotechnology Firms Likely to Continue to Face Macro Headwinds, BofA Securities Says - MarketScreener

Apr 03, 2025
pulisher
Apr 01, 2025

Agios stock touches 52-week low at $27.12 amid market shifts - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Agios stock touches 52-week low at $27.12 amid market shifts By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Mar 26, 2025

Is Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

Agios Pharmaceuticals develops PAH mutant stabilizers for phenylketonuria - BioWorld MedTech

Mar 26, 2025
pulisher
Mar 24, 2025

First Week of November 21st Options Trading For Agios Pharmaceuticals (AGIO) - Nasdaq

Mar 24, 2025
pulisher
Mar 21, 2025

Agios Pharmaceuticals divulges new PAH stabilizers for phenylketonuria - BioWorld MedTech

Mar 21, 2025
pulisher
Mar 19, 2025

Beta Thalassemia Market Predicted to See Upsurge Through 2034, - openPR

Mar 19, 2025
pulisher
Mar 12, 2025

Agios Pharmaceuticals at Barclays Conference: Strategic Advances in Rare Disease Treatments - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Agios Pharm at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 10, 2025

Q1 EPS Estimate for Agios Pharmaceuticals Lowered by Analyst - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

FY2027 Earnings Estimate for AGIO Issued By Zacks Research - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Agios Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer - The Manila Times

Mar 06, 2025
pulisher
Mar 05, 2025

Agios Pharmaceuticals Announces Inducement Equity Awards for New Executive - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate - EIN News

Mar 05, 2025
pulisher
Mar 05, 2025

Celldex Therapeutics and Agios Pharmaceuticals to Present at March 2025 Investor Conferences - Barchart

Mar 05, 2025
pulisher
Mar 05, 2025

Meet Agios' New Strategy Chief: Inside the $2M+ Executive Compensation Deal - Stock Titan

Mar 05, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals chief commercial officer sells $59,742 in stock By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals chief commercial officer sells $59,742 in stock - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals CEO sells shares worth $460,135 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Agios to Present at Upcoming Investor Conferences - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Where to Hear Agios Management Next Month: Key Investor Conferences Revealed - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 - Star Tribune

Mar 01, 2025
pulisher
Mar 01, 2025

Is Agios Pharmaceuticals, Inc. (AGIO) the Best Small-Cap Stock to Buy Now? - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Y Intercept Hong Kong Ltd Acquires Shares of 45,817 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

What is HC Wainwright's Estimate for AGIO Q1 Earnings? - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock rises - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

10 Best Small-Cap Stocks to Buy Now - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Gilbert Cisneros conducts multiple transactions in stocks including Agios Pharmaceuticals and Airbnb - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Sickle Cell Disease Market Growth Projections 2024-2034: - openPR

Feb 27, 2025
pulisher
Feb 27, 2025

Q4 Earnings Estimate for AGIO Issued By HC Wainwright - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Venturi Wealth Management LLC Takes Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

What is HC Wainwright’s Estimate for AGIO Q4 Earnings? - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Agios Bolsters Coffers With $1.1 Bln Milestone Payments Following FDA Approval Of Vorasidenib - RTTNews

Feb 26, 2025
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
大文字化:     |  ボリューム (24 時間):